. 2019 Nov 14;19(4):311–318. doi: 10.1007/s40268-019-00288-x
© The Author(s) 2019
Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Fig. 2.
Dupilumab-associated conjunctivitis management algorithm